Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 55, 2020 - Issue 2
Submit an article Journal homepage
1,317
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis

Aristeidis GrigoriadisDivision of Radiology, Department of Clinical Science, Intervention and Technology (CLINTEC), Stockholm, Sweden; ;Department of Abdominal Radiology, Karolinska University Hospital, Stockholm, Sweden; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3760-3513
ORCID Icon,
Fabian MorsbachDivision of Radiology, Department of Clinical Science, Intervention and Technology (CLINTEC), Stockholm, Sweden; ;Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland;
,
Nikolaos VoulgarakisDepartment of Abdominal Radiology, Karolinska University Hospital, Stockholm, Sweden;
,
Karouk SaidDivision of Hepatology, Department of Upper GI Disease, Karolinska University Hospital, Stockholm, Sweden; ;Department of Medicine Huddinge, Unit of Gastroenterology and Rheumatology, Karolinska Institutet, Stockholm, Sweden
,
Annika BergquistDivision of Hepatology, Department of Upper GI Disease, Karolinska University Hospital, Stockholm, Sweden; ;Department of Medicine Huddinge, Unit of Gastroenterology and Rheumatology, Karolinska Institutet, Stockholm, Sweden
&
Nikolaos KartalisDivision of Radiology, Department of Clinical Science, Intervention and Technology (CLINTEC), Stockholm, Sweden; ;Department of Abdominal Radiology, Karolinska University Hospital, Stockholm, Sweden;
Pages 228-235 | Received 12 Dec 2019, Accepted 18 Jan 2020, Published online: 05 Feb 2020

References

  • Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002;36:321–327.
  • Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181–1188.
  • Weismuller TJ, Trivedi PJ, Bergquist A, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology. 2017;152:1975–1984.e8.
  • Hirschfield GM, Karlsen TH, Lindor KD, et al. Primary sclerosing cholangitis. Lancet. 2013;382:1587–1599.
  • von Seth E, Arnelo U, Enochsson L, et al. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography. Liver Int. 2015;35:254–262.
  • Ali AH, Tabibian JH, Nasser-Ghodsi N, et al. Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology. 2018;67:2338–2351.
  • Charatcharoenwitthaya P, Enders FB, Halling KC, et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008;48:1106–1117.
  • Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. 2011;54:1842–1852.
  • Bjornsson E, Lindqvist-Ottosson J, Asztely M, et al. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:502–508.
  • Hilscher MB, Tabibian JH, Carey EJ, et al. Dominant strictures in primary sclerosing cholangitis: a multicenter survey of clinical definitions and practices. Hepatol Commun. 2018;2:836–844.
  • Stiehl A, Rudolph G, Kloters-Plachky P, et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol. 2002;36:151–156.
  • Chapman RW, Williamson KD. Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma? Curr Hepatology Rep. 2017;16:124–129.
  • Chapman MH, Webster GJ, Bannoo S, et al. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol. 2012;24:1051–1058.
  • Zenouzi R, Liwinski T, Yamamura J, et al.; the International PSC Study Group (IPSCSG). Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret. Aliment Pharmacol Ther. 2018;48:169–178.
  • Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–678.
  • European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–267.
  • Schramm C, Eaton J, Ringe KI, et al.; IPSCSG MRIwgot. Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology. 2017;66:1675–1688.
  • Neri E, Bali MA, Ba-Ssalamah A, et al. ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol. 2016;26:921–931.
  • Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–428.
  • Denecke T, Degutyte E, Stelter L, et al. Minimum intensity projections of the biliary system using 16-channel multidetector computed tomography in patients with biliary obstruction: comparison with MRCP. Eur Radiol. 2006;16:1719–1726.
  • Ruiz A, Lemoinne S, Carrat F, et al. Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology. 2014;59:242–250.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.